12,372 trials
Acute Upper Respiratory Tract Infections
Primary: Percentage of Patients With Recovery/Improvement in Health on Days 2, 3 and 4 of Observation (Based on Patient Diary Data) — 9; 1; 21; 11 percentage of participants…
Liver Neoplasms
Primary: Sensitivity: Percentage of True Positive Lesions Among All Malignant Lesions Per Truth Standard — 48.7; 86.6; 35.3; 75.6 Percentage of true positive lesions — p=<.0001
Iron Deficiency Anaemia · Inflammatory Bowel Disease · Ulcerative Colitis
Primary: Change in Haemoglobin (Hb) Concentration From Baseline to Week 12 (Full Analysis Set, FAS) — 2.26; 0.01 g/dL — p=< 0.0001
Ovarian Cancer · Fallopian Tube Cancer · Peritoneal Cancer
Primary: Disease Progression According to RECIST Version 1.1, as Assessed by the Investigator, or Death From Any Cause (Investigator Progression Free Survival as Per invPFS)…
Acute Upper Respiratory Infections
Primary: Average Illness Duration (the Interval Between the Start of the Trial Treatment and the Time When Recovery/Improvement - Based on Patient Diary Data) — 87.7; 103.3 hours…
Tinea Pedis
Primary: Proportion of Patients in Each Active Treatment Group Who Are Considered a Therapeutic Cure — 96; 81 Participants
Influenza
Primary: Number of Subjects Boosted at Month 12 With Haemagglutinin-inhibition (HI) Antibody Concentrations Above the Cut-off Value — 178 Participants
Poliomyelitis · Diphtheria · Haemophilus Influenzae Type b
Primary: Antibody Concentrations for Pertussis Toxoid (Anti-PT), Filamentous Hemagglutinin (Anti-FHA) and Pertactin (Anti-PRN). — 43.2; 48.3; 24.2; 106.3 IU/mL
Herpes Zoster
Primary: Number of Subjects With a Vaccine Response for Anti-glycoprotein E (gE) Humoral Immunogenicity — 97; 5 Participants
Endometrial Cancer
Primary: Compare the Overall Survival (OS) of Patients Treated With AEZS-108 to the OS of Patients Treated With Doxorubicin. — 196; 188; 60; 67 participants — p=0.5441
Retinopathy of Prematurity
Primary: Percentage of Participants With Absence of Active ROP and Absence of Unfavorable Structural Outcomes in Both Eyes at Week 24 — 80.0; 75.0; 66.2 Percentage of…
Diabetes Mellitus, Type 2 · Hypertension
Primary: Change From Baseline in Glycated Haemoglobin (HbA1c) (%) at 24 Weeks — 0.07; -0.71 percentage of glycated haemoglobin — p=0.0002
Atrial Fibrillation · Percutaneous Coronary Intervention
Primary: Time to First Adjudicated ISTH MBE or CRNMBE — 151; 154; 264; 196 Participants — p=<0.0001
Relapsed Peripheral T-Cell Lymphoma · Refractory Peripheral T-Cell Lymphoma
Primary: Overall Response Rate (ORR) Based on Independent Review Committee (IRC) Assessment — 33; 45 percentage of participants — p=0.038
Cervical Dystonia
Primary: Change From Baseline in the Total Score of the Tsui Rating Scale (Patient in Sitting Position) at the First On-treatment Visit (Week 4 or Week 12) — -3.8; -4.0; -3.8…